Endometriosis Market Forecast 2032: FDA, EMA, PDMA Approvals, Epidemiology, Pipeline Therapies, Clinical Trials, and Companies by DelveInsight | Enteris BioPharma, Spago Nanomedical AB, Nanjing Chia-tai Tianqing Pharmaceutical, Myovant Sciences, Hope Medi

(Albany, USA) DelveInsight's "Endometriosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Endometriosis, historical and forecasted epidemiology as well as the Endometriosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Endometriosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Endometriosis Market Forecast - https://www.delveinsight.com/sample-request/endometriosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of the key facts of the Endometriosis Market Report:
• The Endometriosis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In January 2022, ObsEva SA released favorable initial findings from the Phase 3 EDELWEISS 3 trial concerning linzagolix, an oral GnRH antagonist, indicating positive outcomes for women experiencing moderate to severe endometriosis-associated pain (EAP).
• In February 2022 ObsEva SA revealed a strategic licensing deal with Theramex aiming to facilitate the global market entry and commercialization of linzagolix, excluding the United States, Canada, and Asia. Linzagolix, under development as a prospective remedy for endometriosis-associated pain, recently demonstrated encouraging initial results in its Phase 3 trial (EDELWEISS 3), as announced by ObsEva.
• In 2022, approximately 10,673,000 cases of endometriosis were diagnosed in the 7MM (Seven Major Markets), and these numbers are anticipated to rise by 2032.
• In 2022, within the 7MM, the United States had the highest proportion of diagnosed prevalent cases of endometriosis, making up approximately 44% of these cases. It is projected that these cases will continue to rise by 2032.
• In 2022, the collective number of treated cases of endometriosis across the 7MM amounted to about 6,298,000. According to evaluations by analysts at DelveInsight, these treated cases of endometriosis in the 7MM are projected to see an increase by 2032.
• Key Endometriosis Companies: Enteris BioPharma Inc., Spago Nanomedical AB, Iqvia Pty Ltd, Nanjing Chia-tai Tianqing Pharmaceutical, Myovant Sciences GmbH, Hope Medicine (Nanjing) Co., Ltd, Ferring Pharmaceuticals, Jiangsu HengRui Medicine, ObsEva, AbbVie, ASKA Pharmaceutical Co., Ltd., Abbott, Kissei Pharmaceutical Co., Ltd., Bayer, Pfizer, and others
• Key Endometriosis Therapies: Leuprolide Oral Tablet, SN132D, OG-6219, Elagolix, Relugolix, HMI-115, Quinagolide 1080 µg, OBE2109, SASHR7280, Estradiol/Norethindrone Acetate, TAK-385, NBI-56418 (GnRH antagonist), KLH-2109, Dienogest (Visanne, BAY86-5258), ERB-041, and others
• As per the findings of Yoshino et al. (2022), around 2.6 million women in Japan are impacted by endometriosis.
• The Endometriosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Endometriosis pipeline products will significantly revolutionize the Endometriosis market dynamics.

Endometriosis Overview
Endometriosis is a chronic condition where tissue similar to the lining of the uterus grows outside the womb, commonly causing pelvic pain and infertility. This disorder affects millions of women worldwide. Symptoms may include painful periods, pelvic pain between cycles, and pain during intercourse. The exact cause of endometriosis remains unclear, but factors such as genetics, hormonal imbalances, and immune system dysfunction may contribute. Diagnosis often involves a combination of medical history, physical examination, and imaging tests, with definitive confirmation through laparoscopic surgery and biopsy. Treatment aims to manage symptoms and may include pain medication, hormone therapy, or surgery to remove abnormal tissue. Despite ongoing research and treatment advancements, endometriosis can significantly impact quality of life, emphasizing the need for continued efforts in understanding and managing this condition effectively.

Get a Free sample for the Endometriosis Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/endometriosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Endometriosis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Endometriosis Epidemiology Segmentation:
The Endometriosis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Endometriosis
• Prevalent Cases of Endometriosis by severity
• Gender-specific Prevalence of Endometriosis
• Diagnosed Cases of Episodic and Chronic Endometriosis

Download the report to understand which factors are driving Endometriosis epidemiology trends @ Endometriosis Epidemiology Forecast - https://www.delveinsight.com/sample-request/endometriosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Endometriosis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Endometriosis market or expected to get launched during the study period. The analysis covers Endometriosis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Endometriosis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Endometriosis Therapies and Key Companies
• Leuprolide Oral Tablet: Enteris BioPharma Inc.
• SN132D: Spago Nanomedical AB
• OG-6219: Iqvia Pty Ltd
• Elagolix: Nanjing Chia-tai Tianqing Pharmaceutical
• Relugolix: Myovant Sciences GmbH
• HMI-115: Hope Medicine (Nanjing) Co., Ltd
• Quinagolide 1080 µg: Ferring Pharmaceuticals
• OBE2109: ObsEva
• SASHR7280: Jiangsu HengRui Medicine
• Estradiol/Norethindrone Acetate: AbbVie
• TAK-385: ASKA Pharmaceutical Co., Ltd.
• NBI-56418 (GnRH antagonist): Abbott
• KLH-2109: Kissei Pharmaceutical Co., Ltd.
• Dienogest (Visanne, BAY86-5258): Bayer
• ERB-041: Pfizer

Discover more about therapies set to grab major Endometriosis market share @ Endometriosis Treatment Landscape - https://www.delveinsight.com/sample-request/endometriosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Endometriosis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Endometriosis Companies: Enteris BioPharma Inc., Spago Nanomedical AB, Iqvia Pty Ltd, Nanjing Chia-tai Tianqing Pharmaceutical, Myovant Sciences GmbH, Hope Medicine (Nanjing) Co., Ltd, Ferring Pharmaceuticals, Jiangsu HengRui Medicine, ObsEva, AbbVie, ASKA Pharmaceutical Co., Ltd., Abbott, Kissei Pharmaceutical Co., Ltd., Bayer, Pfizer, and others
• Key Endometriosis Therapies: Leuprolide Oral Tablet, SN132D, OG-6219, Elagolix, Relugolix, HMI-115, Quinagolide 1080 µg, OBE2109, SASHR7280, Estradiol/Norethindrone Acetate, TAK-385, NBI-56418 (GnRH antagonist), KLH-2109, Dienogest (Visanne, BAY86-5258), ERB-041, and others
• Endometriosis Therapeutic Assessment: Endometriosis current marketed and Endometriosis emerging therapies
• Endometriosis Market Dynamics: Endometriosis market drivers and Endometriosis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Endometriosis Unmet Needs, KOL's views, Analyst's views, Endometriosis Market Access and Reimbursement

To know more about Endometriosis companies working in the treatment market, visit @ Endometriosis Clinical Trials and Therapeutic Assessment- https://www.delveinsight.com/sample-request/endometriosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents
1. Endometriosis Market Report Introduction
2. Executive Summary for Endometriosis
3. SWOT analysis of Endometriosis
4. Endometriosis Patient Share (%) Overview at a Glance
5. Endometriosis Market Overview at a Glance
6. Endometriosis Disease Background and Overview
7. Endometriosis Epidemiology and Patient Population
8. Country-Specific Patient Population of Endometriosis
9. Endometriosis Current Treatment and Medical Practices
10. Endometriosis Unmet Needs
11. Endometriosis Emerging Therapies
12. Endometriosis Market Outlook
13. Country-Wise Endometriosis Market Analysis (2019-2032)
14. Endometriosis Market Access and Reimbursement of Therapies
15. Endometriosis Market Drivers
16. Endometriosis Market Barriers
17. Endometriosis Appendix
18. Endometriosis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Trending Reports:
Trending Reports:
• Asphyxia Market: https://www.delveinsight.com/report-store/asphyxia-market
• Asherman's Syndrome Market: https://www.delveinsight.com/report-store/ashermans-syndrome-market
• Acute Agitation And Aggression Market: https://www.delveinsight.com/report-store/acute-agitation-and-aggression-market
• Abetalipoproteinemia Market: https://www.delveinsight.com/report-store/abetalipoproteinemia-market
• Chronic pruritus market: https://www.delveinsight.com/report-store/chronic-pruritus-market
• Hiatal hernia market: https://www.delveinsight.com/report-store/hiatal-hernia-market
• Pediatric obesity market: https://www.delveinsight.com/report-store/pediatric-obesity-market
• Acral Lentiginous Melanoma Market: https://www.delveinsight.com/report-store/acral-lentiginous-melanoma-market
• Anaphylaxis Market: https://www.delveinsight.com/report-store/anaphylaxis-market
• Aortic Stenosis Market: https://www.delveinsight.com/report-store/aortic-stenosis-market
• Binge Eating Disorder Market: https://www.delveinsight.com/report-store/binge-eating-disorders-market
• Chronic Myelogenous Leukemia Market: https://www.delveinsight.com/report-store/chronic-myelogenous-leukemia-market
• Familial Primary Pulmonary Hypertension Market: https://www.delveinsight.com/report-store/familial-primary-pulmonary-hypertension-market
• Hpv-induced Cancers Market: https://www.delveinsight.com/report-store/hpv-induced-cancers-market
• Meningioma Market: https://www.delveinsight.com/report-store/meningioma-market
• Optic Neuritis Market: https://www.delveinsight.com/report-store/optic-neuritis-market
• Partial Seizure Market: https://www.delveinsight.com/report-store/partial-seizure-market
• Progressive Multifocal Leukoencephalopathy Market: https://www.delveinsight.com/report-store/progressive-multifocal-leukoencephalopathy-market
• Alopecia Market: https://www.delveinsight.com/report-store/alopecia-market
• Cluster Headache Market: https://www.delveinsight.com/report-store/cluster-headache-market
• Minimal Residual Disease Market: https://www.delveinsight.com/report-store/minimal-residual-disease-market
• Achondroplasia Market: https://www.delveinsight.com/report-store/achondroplasia-market
• Actinic Keratosis Market: https://www.delveinsight.com/report-store/actinic-keratosis-market
• Aesthetic Implants Market: https://www.delveinsight.com/report-store/aesthetic-implants-market
• Alzheimer Disease Market: https://www.delveinsight.com/report-store/alzheimers-disease-ad-market
• Angioedema Market: https://www.delveinsight.com/report-store/angioedema-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Calciphylaxis Market: https://www.delveinsight.com/report-store/calciphylaxis-pipeline-insight
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Chemotherapy Induced Thrombocytopenia Market: https://www.delveinsight.com/report-store/chemotherapy-induced-thrombocytopenia-market-size
• Chronic Lymphocytic Leukemia Cll Market: https://www.delveinsight.com/report-store/chronic-lymphocytic-leukemia-cll-market
• Concussions Market Size: https://www.delveinsight.com/report-store/concussions-market
• Eczema Market: https://www.delveinsight.com/report-store/eczema-market
• Foot And Ankle Devices Market: https://www.delveinsight.com/report-store/foot-and-ankle-devices-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Hyperhidrosis Market: https://www.delveinsight.com/report-store/hyperhidrosis-market
• Ventricular Hypertrophy Market: https://www.delveinsight.com/report-store/hypertrophic-cardiomyopathy-pipeline-insight
• Cerebral Aneurysm Market: https://www.delveinsight.com/report-store/intracranial-aneurysms-market-insight
• Lewy Body Dementia Market: https://www.delveinsight.com/report-store/lewy-body-dementia-market
• Multiple Myeloma Market: https://www.delveinsight.com/report-store/multiple-myeloma-market
• Pressure Ulcers Market Size: https://www.delveinsight.com/report-store/negative-pressure-wound-therapy-systems-market
• Neuroblastoma Market: https://www.delveinsight.com/report-store/neuroblastoma-market
• Neurostimulation Devices Market: https://www.delveinsight.com/report-store/neurostimulation-devices-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Nsclc Market: https://www.delveinsight.com/report-store/non-small-cell-lung-cancer-nsclc-market
• Opioid Induced Constipation Market: https://www.delveinsight.com/report-store/opioid-induced-constipation-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/osteoarthritis-market
• Parkinson's Disease Market: https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment
• Pruritus Market: https://www.delveinsight.com/report-store/pruritus-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Chronic Lymphocytic Leukemia Market: https://www.delveinsight.com/report-store/relapsed-chronic-lymphocytic-leukemia-cll-market
• Ventilator Market: https://www.delveinsight.com/report-store/ventilators-market

Contact Us
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.